ArticleiScience2018

Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer.

Donghai Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.